Mesoblast Reports Financial Results and Corporate Highlights for First Half Ended December 31, 2019

    NEXT STORY
    ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference
    PREV STORY
    Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Advaxis Announces Agreement with Columbia University Irving Medical Center to Fund Phase 1 Study of ADXS-504 for the Treatment of Early Prostate Cancer

    author_avatar
    NASDAQ Market News

    Sensus Healthcare to Participate in Three Investment Conferences During the Month of March

    author_avatar
    NASDAQ Market News

    Présentation de données cliniques et précliniques sur monalizumab au congrès annuel 2017 de l’AACR

    PRÉSENTATION DE DONNÉES CLiNIQUES ET PRÉCLINIQUES sur MONALIZUMAB AU CONGRÈS ANNUEL 2017 DE l'AACR ...

    author_avatar
    NASDAQ Market News